ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,071Medicare Part D Prescriptions Filled, Including Refills

Rank: 384 out of 972

$477K Total Retail Price of All Prescriptions

Rank: 344 out of 972

658 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
16% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 658 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 658 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 7,282 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
LEVOTHYROXINE SODIUM 316 296 1 3
LISINOPRIL 294 283 2 1
SIMVASTATIN 282 257 3 2
HYDROCODONE-ACETAMINOPHEN 240 171 S3 4 6
ZOLPIDEM TARTRATE 234 228 5 23
OMEPRAZOLE 198 187 6 5
AMLODIPINE BESYLATE 189 177 7 4
ATORVASTATIN CALCIUM 148 143 8 11
HYDROCHLOROTHIAZIDE 133 129 9 10
ATENOLOL 131 127 10 18
LOSARTAN POTASSIUM 130 124 11 17
TRIAMTERENE-HCTZ 124 102 12 39
METOPROLOL TARTRATE 115 96 13 9
TRAZODONE HCL 106 95 14 35
FUROSEMIDE 105 103 15 7
WARFARIN SODIUM 102 88 16 12
GABAPENTIN 97 86 17 14
PRAVASTATIN SODIUM 88 78 18 20
AZITHROMYCIN 83 73 19 42
METFORMIN HCL ER 83 68 19 62
METOPROLOL SUCCINATE 77 72 21 16
METFORMIN HCL 72 56 22 8
ALLOPURINOL 70 69 23 28
ADVAIR DISKUS 65 61 24 45
CITALOPRAM HBR 63 62 25 19
DONEPEZIL HCL 63 63 25 26
TRAMADOL HCL 62 61 27 15
HYDRALAZINE HCL 62 62 27 69
PANTOPRAZOLE SODIUM 61 44 29 41
CARVEDILOL 56 53 30 21
PREDNISONE 56 51 30 40
CELEBREX 54 54 32 85
NAMENDA 53 53 33 38
MELOXICAM 53 50 33 36
RANITIDINE HCL 53 52 33 24
MIRTAZAPINE 52 43 36 46
OXYCODONE-ACETAMINOPHEN 51 45 S2 37 80
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 17, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.